Novel GLP-1-Based Medications for Type 2 Diabetes and Obesity
- Son JW, le Roux CW, Blüher M, Nauck MA, Lim S. Novel GLP-1-Based Medications for Type 2 Diabetes and Obesity Endocr Rev
Publication Category: Metabolic Health
Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease
-
Sedrak P, Verma R, Verma M, Connelly KA.
Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease The Canadian Journal of Cardiology
Metallomic profiles of pregnant women living with obesity in the UK: a secondary analysis of UPBEAT
-
Agostinho de Sousa J, Griffiths A, Dalrymple KV, White SL, von Meyenn F, Poston L, Rigutto-Farebrother J, Flynn AC.
Metallomic profiles of pregnant women living with obesity in the UK: a secondary analysis of UPBEAT Metallomics
Effects of Whole-Body Cryotherapy Combined With Conventional Obesity Management Versus Obesity Management Alone: A Clinical Trial
-
Karppinen JE, Suojanen L, Heinonen S, Kaye S, van der Kolk BW, White JW, Orava J, Lee SHT, Dillon E, Muniandy M, Rissanen A, le Roux CW, Docherty N, Pajukanta P, Virtanen KA, Pietiläinen KH.
Effects of Whole-Body Cryotherapy Combined With Conventional Obesity Management Versus Obesity Management Alone: A Clinical Trial Obesity (Silver Spring)
PCOS and Obesity: Contraception Challenges
- Meczekalski B, Rasi M, Battipaglia C, Fidecicchi T, Bala G, Szeliga A, Luisi S, Genazzani AD. PCOS and Obesity: Contraception Challenges Open Access Journal of Contraception
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
- Feng G, Targher G, Byrne CD, Yilmaz Y, Wai-Sun Wong V, Adithya Lesmana CR, Adams LA, Boursier J, Papatheodoridis G, El-Kassas M, Méndez-Sánchez N, Sookoian S, Castera L, Chan WK, Ye F, Treeprasertsuk S, Cortez-Pinto H, Yu HH, Kim W, Romero-Gómez M, Nakaji Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021 JHEP Rep
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities
- Bailey CJ, Flatt PR, Conlon JM. Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbidities The Journal of Peptide Science
The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: 2010 to 2021
- Lorek D, Lupina K, Bisaga W, Malicki D, Stepien W, Kumor L, Janczura J. The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: 2010 to 2021 JHEP Reports
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
-
Elshorbagy A, Vallejo-Vaz AJ, Barkas F, Lyons ARM, Stevens CAT, Dharmayat KI, Catapano AL, Freiberger T, Hovingh GK, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Alhabib KF, Alkhnifsawi M, Almahmeed W, Alnouri F, Alonso R
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry European Heart Journal
A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure
-
Gul U, Aung T, Martin M, Farrukh DN, Shah PC, Lovely ZS, Marroquín León E, Alansaari M, Maini S, Fariduddin MM, Ullah A, Nazir Z.
A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure Cureus